Bristows and ArentFox Schiff advised NASDAQ-listed GBS Inc. on the deal. GBS Inc. – a life sciences company developing non-invasive, real-time diagnostic testing for patients and...
You must be a Standard 1 Year member to access this content.
Schiff Hardin LLP assisted Dawson James Securities on the deal. Smart for Life, Inc. announced its $14.4 million initial public offering. Smart for Life is a leading...
You must be a Standard 1 Year member to access this content.
Schiff Hardin LLP advised CNS Pharmaceuticals, Inc. on the deal. CNS Pharmaceuticals, Inc. announced its public offering of 5,750,000 shares of common stock and 2,875,000 warrants to...
You must be a Standard 1 Year member to access this content.
